dr. tagawa on sacituzumab govitecan in urothelial carcinoma
Published 5 years ago • 145 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:18
dr. tagawa on next steps with sacituzumab govitecan in advanced urothelial carcinoma
-
1:40
dr. tagawa on immu-132 trial updates in urothelial cancer
-
1:10
use of sacituzumab govitecan in metastatic urothelial carcinoma
-
2:40
dr. bardia on sacituzumab govitecan in triple-negative breast cancer
-
1:31
dr. scott tagawa discusses immu-132 in patients with urothelial carcinoma
-
2:02
sacituzumab govitecan in the treatment of metastatic urothelial carcinoma
-
6:37
sacituzumab govitecan in patients with previously treated metastatic urothelial cancer
-
2:04
dr. tagawa discusses the development of immunotherapy in urothelial cancer
-
1:01
dr. graff on the use of sacituzumab govitecan in breast cancer
-
6:01
sacituzumab govitecan given accelerated fda approval for advanced urothelial cancer
-
5:01
sacituzumab govitecan in patients with previously treated muc
-
3:53
sacituzumab govitecan in metastatic urothelial carcinoma: updates on the phase ii study
-
6:06
sacituzumab govitecan in patients with platinum-refractory metastatic urothelial cancer
-
1:16
antibody-drug conjugates in advanced urothelial cancer: sacituzumab govitecan
-
6:17
antibody-drug conjugates in tnbc: sacituzumab govitecan
-
1:47
dr. bardia on sacituzumab govitecan in tnbc
-
4:25
trophy-u-01: sacituzumab govitecan in patients with muc after failure of platinum-based regimens...
-
5:27
sacituzumab govitecan demonstrates metastatic urothelial cancer benefit | yohann loriot
-
4:34
neoadjuvant sacituzumab govitecan showed promising activity in muscle-invasive urothelial bladde...